| Home > Publications Database > SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. > print |
| 001 | 163322 | ||
| 005 | 20240221135622.0 | ||
| 024 | 7 | _ | |a 10.1016/j.cell.2021.11.033 |2 doi |
| 024 | 7 | _ | |a pmid:34914922 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC8626230 |2 pmc |
| 024 | 7 | _ | |a 0092-8674 |2 ISSN |
| 024 | 7 | _ | |a 1097-4172 |2 ISSN |
| 024 | 7 | _ | |a altmetric:117716540 |2 altmetric |
| 037 | _ | _ | |a DZNE-2022-00102 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Wendisch, Daniel |b 0 |
| 245 | _ | _ | |a SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. |
| 260 | _ | _ | |a New York, NY |c 2021 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1708519994_22070 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a COVID-19-induced 'acute respiratory distress syndrome' (ARDS) is associated with prolonged respiratory failure and high mortality, but the mechanistic basis of lung injury remains incompletely understood. Here, we analyze pulmonary immune responses and lung pathology in two cohorts of patients with COVID-19 ARDS using functional single-cell genomics, immunohistology, and electron microscopy. We describe an accumulation of CD163-expressing monocyte-derived macrophages that acquired a profibrotic transcriptional phenotype during COVID-19 ARDS. Gene set enrichment and computational data integration revealed a significant similarity between COVID-19-associated macrophages and profibrotic macrophage populations identified in idiopathic pulmonary fibrosis. COVID-19 ARDS was associated with clinical, radiographic, histopathological, and ultrastructural hallmarks of pulmonary fibrosis. Exposure of human monocytes to SARS-CoV-2, but not influenza A virus or viral RNA analogs, was sufficient to induce a similar profibrotic phenotype in vitro. In conclusion, we demonstrate that SARS-CoV-2 triggers profibrotic macrophage responses and pronounced fibroproliferative ARDS. |
| 536 | _ | _ | |a 354 - Disease Prevention and Healthy Aging (POF4-354) |0 G:(DE-HGF)POF4-354 |c POF4-354 |f POF IV |x 0 |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a ARDS |2 Other |
| 650 | _ | 7 | |a COVID-19 |2 Other |
| 650 | _ | 7 | |a IPF |2 Other |
| 650 | _ | 7 | |a SARS-CoV-2 |2 Other |
| 650 | _ | 7 | |a fibrosis |2 Other |
| 650 | _ | 7 | |a lung |2 Other |
| 650 | _ | 7 | |a macrophages |2 Other |
| 650 | _ | 7 | |a monocytes |2 Other |
| 650 | _ | 7 | |a proteomics |2 Other |
| 650 | _ | 7 | |a pulmonary fibrosis |2 Other |
| 650 | _ | 7 | |a single-cell transcriptomics |2 Other |
| 650 | _ | 7 | |a Antigens, CD |2 NLM Chemicals |
| 650 | _ | 7 | |a Antigens, Differentiation, Myelomonocytic |2 NLM Chemicals |
| 650 | _ | 7 | |a CD163 antigen |2 NLM Chemicals |
| 650 | _ | 7 | |a Proteome |2 NLM Chemicals |
| 650 | _ | 7 | |a Receptors, Cell Surface |2 NLM Chemicals |
| 650 | _ | 2 | |a Antigens, CD: metabolism |2 MeSH |
| 650 | _ | 2 | |a Antigens, Differentiation, Myelomonocytic: metabolism |2 MeSH |
| 650 | _ | 2 | |a COVID-19: diagnostic imaging |2 MeSH |
| 650 | _ | 2 | |a COVID-19: pathology |2 MeSH |
| 650 | _ | 2 | |a COVID-19: virology |2 MeSH |
| 650 | _ | 2 | |a Cell Communication |2 MeSH |
| 650 | _ | 2 | |a Cohort Studies |2 MeSH |
| 650 | _ | 2 | |a Fibroblasts: pathology |2 MeSH |
| 650 | _ | 2 | |a Gene Expression Regulation |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Idiopathic Pulmonary Fibrosis: diagnostic imaging |2 MeSH |
| 650 | _ | 2 | |a Idiopathic Pulmonary Fibrosis: genetics |2 MeSH |
| 650 | _ | 2 | |a Idiopathic Pulmonary Fibrosis: pathology |2 MeSH |
| 650 | _ | 2 | |a Idiopathic Pulmonary Fibrosis: virology |2 MeSH |
| 650 | _ | 2 | |a Macrophages: pathology |2 MeSH |
| 650 | _ | 2 | |a Macrophages: virology |2 MeSH |
| 650 | _ | 2 | |a Mesenchymal Stem Cells: pathology |2 MeSH |
| 650 | _ | 2 | |a Phenotype |2 MeSH |
| 650 | _ | 2 | |a Proteome: metabolism |2 MeSH |
| 650 | _ | 2 | |a Receptors, Cell Surface: metabolism |2 MeSH |
| 650 | _ | 2 | |a Respiratory Distress Syndrome: diagnostic imaging |2 MeSH |
| 650 | _ | 2 | |a Respiratory Distress Syndrome: pathology |2 MeSH |
| 650 | _ | 2 | |a Respiratory Distress Syndrome: virology |2 MeSH |
| 650 | _ | 2 | |a SARS-CoV-2: physiology |2 MeSH |
| 650 | _ | 2 | |a Tomography, X-Ray Computed |2 MeSH |
| 650 | _ | 2 | |a Transcription, Genetic |2 MeSH |
| 700 | 1 | _ | |a Dietrich, Oliver |b 1 |
| 700 | 1 | _ | |a Mari, Tommaso |b 2 |
| 700 | 1 | _ | |a von Stillfried, Saskia |b 3 |
| 700 | 1 | _ | |a Ibarra, Ignacio L |b 4 |
| 700 | 1 | _ | |a Mittermaier, Mirja |b 5 |
| 700 | 1 | _ | |a Mache, Christin |b 6 |
| 700 | 1 | _ | |a Chua, Robert Lorenz |b 7 |
| 700 | 1 | _ | |a Knoll, Rainer |0 P:(DE-2719)9000620 |b 8 |u dzne |
| 700 | 1 | _ | |a Timm, Sara |b 9 |
| 700 | 1 | _ | |a Brumhard, Sophia |b 10 |
| 700 | 1 | _ | |a Krammer, Tobias |b 11 |
| 700 | 1 | _ | |a Zauber, Henrik |b 12 |
| 700 | 1 | _ | |a Hiller, Anna Luisa |b 13 |
| 700 | 1 | _ | |a Pascual-Reguant, Anna |b 14 |
| 700 | 1 | _ | |a Mothes, Ronja |b 15 |
| 700 | 1 | _ | |a Bülow, Roman David |b 16 |
| 700 | 1 | _ | |a Schulze, Jessica |b 17 |
| 700 | 1 | _ | |a Leipold, Alexander M |b 18 |
| 700 | 1 | _ | |a Djudjaj, Sonja |b 19 |
| 700 | 1 | _ | |a Erhard, Florian |b 20 |
| 700 | 1 | _ | |a Geffers, Robert |b 21 |
| 700 | 1 | _ | |a Pott, Fabian |b 22 |
| 700 | 1 | _ | |a Kazmierski, Julia |b 23 |
| 700 | 1 | _ | |a Radke, Josefine |b 24 |
| 700 | 1 | _ | |a Pergantis, Panagiotis |b 25 |
| 700 | 1 | _ | |a Baßler, Kevin |0 P:(DE-2719)9000836 |b 26 |u dzne |
| 700 | 1 | _ | |a Conrad, Claudia |b 27 |
| 700 | 1 | _ | |a Aschenbrenner, Anna C |0 P:(DE-2719)2812913 |b 28 |u dzne |
| 700 | 1 | _ | |a Sawitzki, Birgit |b 29 |
| 700 | 1 | _ | |a Landthaler, Markus |b 30 |
| 700 | 1 | _ | |a Wyler, Emanuel |b 31 |
| 700 | 1 | _ | |a Horst, David |b 32 |
| 700 | 1 | _ | |a Initiative, Deutsche COVID-19 OMICS |b 33 |e Collaboration Author |
| 700 | 1 | _ | |a Hippenstiel, Stefan |b 34 |
| 700 | 1 | _ | |a Hocke, Andreas |b 35 |
| 700 | 1 | _ | |a Heppner, Frank L |0 P:(DE-2719)2812386 |b 36 |u dzne |
| 700 | 1 | _ | |a Uhrig, Alexander |b 37 |
| 700 | 1 | _ | |a Garcia, Carmen |b 38 |
| 700 | 1 | _ | |a Machleidt, Felix |b 39 |
| 700 | 1 | _ | |a Herold, Susanne |b 40 |
| 700 | 1 | _ | |a Elezkurtaj, Sefer |b 41 |
| 700 | 1 | _ | |a Thibeault, Charlotte |b 42 |
| 700 | 1 | _ | |a Witzenrath, Martin |b 43 |
| 700 | 1 | _ | |a Cochain, Clément |b 44 |
| 700 | 1 | _ | |a Suttorp, Norbert |b 45 |
| 700 | 1 | _ | |a Drosten, Christian |b 46 |
| 700 | 1 | _ | |a Goffinet, Christine |b 47 |
| 700 | 1 | _ | |a Kurth, Florian |b 48 |
| 700 | 1 | _ | |a Schultze, Joachim L |0 P:(DE-2719)2811660 |b 49 |u dzne |
| 700 | 1 | _ | |a Radbruch, Helena |b 50 |
| 700 | 1 | _ | |a Ochs, Matthias |b 51 |
| 700 | 1 | _ | |a Eils, Roland |b 52 |
| 700 | 1 | _ | |a Müller-Redetzky, Holger |b 53 |
| 700 | 1 | _ | |a Hauser, Anja E |b 54 |
| 700 | 1 | _ | |a Luecken, Malte D |b 55 |
| 700 | 1 | _ | |a Theis, Fabian J |b 56 |
| 700 | 1 | _ | |a Conrad, Christian |b 57 |
| 700 | 1 | _ | |a Wolff, Thorsten |b 58 |
| 700 | 1 | _ | |a Boor, Peter |b 59 |
| 700 | 1 | _ | |a Selbach, Matthias |b 60 |
| 700 | 1 | _ | |a Saliba, Antoine-Emmanuel |b 61 |
| 700 | 1 | _ | |a Sander, Leif Erik |b 62 |
| 773 | _ | _ | |a 10.1016/j.cell.2021.11.033 |g Vol. 184, no. 26, p. 6243 - 6261.e27 |0 PERI:(DE-600)2001951-8 |n 26 |p 6243 - 6261.e27 |t Cell |v 184 |y 2021 |x 0092-8674 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/163322/files/DZNE-2022-00102_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/163322/files/DZNE-2022-00102_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:163322 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)9000620 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 26 |6 P:(DE-2719)9000836 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 28 |6 P:(DE-2719)2812913 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 36 |6 P:(DE-2719)2812386 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 49 |6 P:(DE-2719)2811660 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-354 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Prevention and Healthy Aging |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 1 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-03 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-03 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2022-11-09 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL : 2021 |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-09 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-09 |
| 915 | _ | _ | |a IF >= 60 |0 StatID:(DE-HGF)9960 |2 StatID |b CELL : 2021 |d 2022-11-09 |
| 920 | 1 | _ | |0 I:(DE-2719)1013031 |k Schultze - PRECISE |l Platform for Single Cell Genomics and Epigenomics |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)5000031 |k R&D PRECISE |l Platform for Single Cell Genomics and Epigenomics at DZNE & University of Bonn |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1810007 |k AG Heppner |l Neuroimmunology |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1013031 |
| 980 | _ | _ | |a I:(DE-2719)5000031 |
| 980 | _ | _ | |a I:(DE-2719)1810007 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|